Skip to content
2000
Volume 4, Issue 6
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

The design of selective COX-2 inhibitors is a new approach to obtain potent, anti-inflammatory drugs but with less side effects. Several families of such inhibitors were reported in literature. In this review, the drug design processes used to understand their binding mode and the origin of selectivity of these compounds are described.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557043403756
2004-08-01
2025-09-30
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557043403756
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test